| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEE | 1,759 | |||
| PROFESSIONAL FEES |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC | 2020-11 | PURCHASE | 2021-07 | 34,981 | 24,546 | 10,435 | ||||
| TESLA INC | 2020-11 | PURCHASE | 2021-11 | 95,215 | 39,426 | 55,789 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| MARKETABLE SECURITIES | AT COST | 412,518 | |
| ADJUST TO MARKET | 41,488 |
| Description | Amount |
|---|---|
| DECREASE IN MARKET VALUE ADJUTMENT | 92,082 |
| EXCISE TAX PAYMENTS MADE | 128 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| ADVERTISING EXPENSE | 74 | |||
| INVESTMENT FEES | 150 | |||
| MISCELLANEOUS | 40 |